| Walnut consumption in hyperlipidemic patients. | |
| | |
MedLine Citation:
|
PMID: 16193197 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Walnut (Juglans regia L.) is described as an anticancer, tonic, blood purifier, and detoxifier agent. It is said that nuts have favorable fatty acids and nutrients. This study was performed to determine the lipid-lowering properties of walnut in a population in Shiraz, Southern Iran. In a randomized case-control study, 52 volunteers were divided into 2 groups: Group A consumed walnuts, 20 grams per day for 8 weeks and the control group (group B) consumed no walnuts. Triglycerides, total high-density lipoprotein (HDL), and low-density lipoprotein (LDL) levels were checked for each subject prior to, after 4 weeks, and at 8 weeks after the beginning of the study. In group A, the mean plasma TG level dropped by 17.1% from the baseline and HDL cholesterol also increased significantly by 9%. It was shown that frequent consumption of nuts in the daily diet was associated with a potentially decreased risk of coronary artery disease by decreasing the level of triglyceride and increasing the level of HDL. |
| | |
Authors:
|
M J Zibaeenezhad; S J Shamsnia; M Khorasani |
Related Documents
:
|
19865527 - Sage tea drinking improves lipid profile and antioxidant defences in humans. 19013187 - Impact of progressive resistance training on lipids and lipoproteins in adults: a meta-... 17685887 - Present-day uses of niacin: effects on lipid and non-lipid parameters. 2239777 - Erythrocyte fatty acids, plasma lipids, and cardiovascular disease in rural china. 16698067 - Effect of crude oil contaminated sediment exposure on cytochrome p450 enzymes in the au... 16457997 - Dietary docosahexaenoic acid alters pregnant rat reproductive tissue prostaglandin and ... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Angiology Volume: 56 ISSN: 0003-3197 ISO Abbreviation: Angiology Publication Date: 2005 Sep-Oct |
Date Detail:
|
Created Date: 2005-09-29 Completed Date: 2005-11-14 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0203706 Medline TA: Angiology Country: United States |
Other Details:
|
Languages: eng Pagination: 581-3 Citation Subset: IM |
Affiliation:
|
Cardiovascular Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Zibaeem2@sums.ac.ir |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cholesterol, HDL
/
blood Cholesterol, LDL / blood Coronary Artery Disease / prevention & control Humans Hyperlipidemias / drug therapy* Juglans* Phytotherapy* Plant Preparations / therapeutic use* Risk Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Plant Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The glucose tolerance test, but not HbA(1c), remains the gold standard in identifying unrecognized d...
Next Document: Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?